Company intelligence / Profile preview

Elira

St. Louis, Missouri, United Statesyoutube.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Elira has developed a non-invasive, drug-free wearable neurostimulation patch designed to suppress appetite and control hunger in overweight adults. The technology modulates nervous system activity to assist with weight loss. The company has filed 20 patents related to electrotherapy and neurotechnology for weight management. No published clinical trial results are available as of now.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Elira.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elira.

Explore the full profile